Angiogenesis, the growth of new capillaries from preexisting ones, occurs through dynamic functions of the endothelial cells (EC), including migration, which is essential to achieve an organized formation of the vessel sprout. We demonstrated previously that an aspirintriggered lipoxin analog, 15-epi-16-(para-fluoro)-phenoxylipoxin A 4 (ATL-1), inhibits vascular endothelial growth factor (VEGF)-induced EC migration. In the present study, we investigated the effects of ATL-1 in the actin cytoskeleton reorganization of EC stimulated with VEGF. Pretreatment of EC with ATL-1 caused a reduction in VEGF-induced stress fibers and therefore reduced the intracellular content of filamentous actin. A concomitant impairment in stress-activated protein kinase (SAPK2/ p38) phosphorylation suggests that ATL inhibition of VEGF-stimulated actin polymerization involves the SAPK2/p38 pathway. Moreover, ATL-1 treatment inhibited focal adhesion clustering due to inhibition of focal adhesion kinase (FAK) phosphorylation and the subsequent association of FAK with the actin cytoskeleton. This final event, which ultimately allows cell migration, was reverted by an LX receptor antagonist, but not by a cys-LT1R antagonist, indicating an effect via the Gprotein-linked LXA 4 receptor. Together our results provide evidence that ATL-1 inhibits EC migration via the concerted inhibition of actin polymerization and proper assembly of focal adhesions, supporting a role for these novel lipid mediators as angiogenesis modulators.
Introduction
Angiogenesis, the sprouting of new blood vessels from pre-existing endothelium, is an important component of embryonic vascular development, wound healing, and organ regeneration, but it also contributes to the progression of pathologies that depend on neovascularization, including diabetic retinopathies, rheumatoid arthritis, and tumor growth (Folkman and Shing, 1992; Folkman, 1995) .
Endothelial cells (EC) are normally quiescent, becoming activated during the angiogenic response. Upon stimulation, EC can degrade the proximal extracellular matrix, migrate directionally, then divide and organize into functional capillaries, steps induced and regulated by a network of mitogens and cytokines (Arenberg and Strieter, 1999; Strieter et al., 2004) . Although there are potentially numerous angiogenic factors, considerable evidence has accumulated indicating that vascular endothelial growth factor (VEGF) is essential and is probably the most important factor for the development and differentiation of the vascular system (Ferrara et al., 2003) . VEGF exerts its biological effects by binding to either of two cell surface receptors: VEGFR-1 (also called Flt-1) or VEGFR-2 (KDR/Flk-1) (Shibuya et al., 1999) . Binding of VEGF to the extracellular domains of the receptor leads to autophosphorylation, with subsequent induction of kinase activity and transphosphorylation of several cytoplasmic signaling proteins, including mitogen-activated protein (MAP) kinases (extracellular signal-regulated protein kinase (ERK) and stress-activated protein kinase (SAPK2/p38 MAP kinase)) and phosphatidylinositol 3-kinase (PI 3-kinase) (Zachary, 2003) .
Nonsteroidal anti-inflammatory drugs, such as aspirin (ASA), have been suggested to prevent certain types of cancer, such as lung, colon, and breast cancers, and its mechanism of action is thought to result from antiangiogenic activity (Shtivelband et al., 2003; Wang and DuBois, 2004) . ASAs therapeutic mechanism of action includes inhibition of COX-2-derived prostanoids (Vane, 2000) . In addition, when acetylated by ASA, COX-2 ability to generate prostanoids is blocked, but remains active in EC to induce the biosynthesis of ASAtriggered-15-epi-lipoxin A 4 (ATL) (Cla`ria and Serhan, 1995) . These novel endogenous lipid mediators are the carbon 15 epimers of the native lipoxins (LX) and mimic some of their bioactivities (Serhan, 1999) . ATL have been shown to be generated in vivo during cell-cell interactions, such as EC-neutrophils (Chiang et al., 1998) , and display potent inhibitory actions in several key events in inflammation. In view of the rapid transformation and inactivation of LX and ATL, it was highly desirable to design analogs that would resist metabolism and maintain their structural integrity. To that end, LX analogs were constructed with specific modifications of the native structures that prolong the half-life of the compounds in blood and enhance their bioavailability and bioactivity (Clish et al., 1999) .
We have recently reported that 15-epi-16-(parafluoro)-phenoxy-lipoxin A 4 , an ATL synthetic analog, inhibited VEGF-stimulated EC migration, an essential component of the angiogenic process, in a concentration-dependent manner, with an IC 50 B3 nM (Fierro et al., 2002) . In the present study, we investigated the mechanisms involved in this inhibitory action. We found that the analog, namely ATL-1, modulates two essential components of the motile process, impairing actin polymerization and focal adhesion assembly. These results provide an insight into how these novel lipid mediators may modulate angiogenesis in pathological settings.
Results

ATL-1 inhibits VEGF-induced actin cytoskeleton reorganization
Since VEGF plays an important role in EC migration by regulating actin dynamics and organization, we initially investigated the ability of 15-epi-16-(parafluoro)-phenoxy-lipoxin A 4 (ATL-1), to modulate actin cytoskeleton reorganization.
Staining of HUVEC with rhodamin-conjugated phalloidin showed that in unstimulated (control) cells, filamentous actin is characteristically organized in cortical arrays (Figure 1a ). VEGF treatment (3 ng/ml) stimulates an increase in actin filament formation, and, in particular, increases the number of transverse filament bundles that cross the cells (Figure 1c) . We then examined whether these changes on the actin filament network could be affected by ATL-1. Pretreatment of the cells with different concentrations of the analog for 30 min causes a visible reduction in VEGFinduced stress fibers, with a more marked effect at higher concentrations (Figure 1d-f) . Conversely, ATL-1 alone does not evoke remarkable perturbations in the actin filament (Figure 1b) . The number of stress fibers following each treatment was quantified and is shown in Table 1 . Confirming these findings, Figure 2 shows the cellular content of actin in EC treated with the analog, as measured by immunoblotting. EC exhibit similar levels of nonpolymerized globular(G)-actin under resting conditions (lane 1) or after stimulation (lanes 2-4). Treatment with VEGF (lane 2) induces actin polymerization, which is abrogated by ATL-1 (100 nM) (lane 3). Filamentous(F)-actin content is not affected by the analog per se, with ATL-treated cells maintaining a profile similar to that of control cells (lane 4).
VEGF-induced p38 phosphorylation is inhibited by ATL-1
It has been previously demonstrated that EC migration is dependent on the activation of p38 by VEGF, a phenomenon tightly associated with formation of stress Figure 1 ATL-1 inhibits VEGF-induced actin cytoskeleton reorganization. HUVEC plated on gelatin-coated coverslips were treated with vehicle (medium plus 0.05% ethanol) (a) or were exposed for 15 min to 100 nM ATL-1 (b) or 3 ng/ml VEGF (c) or were pretreated for 30 min, respectively, with 1 nM (d), 10 nM (e) and 100 nM (f) ATL-1 before exposure to VEGF (3 ng/ml) for 15 min. Cells were fixed and permeabilized, and F-actin content was detected using rhodamin-conjugated phalloidin. Coverslips were mounted onto microscope slides and analysed under an epifluorescence microscope (Olympus BX40). The results shown are representative of at least 15 different fields observed in each experiment and of three similar independent experiments. fibers (Rousseau et al., 1997) . In order to investigate whether ATL-induced inhibition of VEGF-stimulated actin polymerization involved the p38 pathway, the kinase was immunoprecipitated from untreated HU-VEC or HUVEC incubated with ATL (100 nM) or VEGF (3 ng/ml) or pretreated with ATL (1-100 nM) prior to exposure to VEGF. As illustrated in Figure 3 , preincubation with ATL-1 blocks VEGF-induced p38 phosphorylation in HUVEC in a dose-dependent manner.
ATL-1 inhibits VEGF-induced FAK phosphorylation at focal adhesion sites There is increasing evidence that focal adhesion kinase (FAK), a nonreceptor protein tyrosine kinase, may play a role in regulating the dynamic changes in actin cytoskeleton organization. FAK is associated with focal adhesions, specialized subcellular structures that play a crucial role in mediating cell adhesion and motility. Tyrosine phosphorylation of FAK is stimulated by growth factor ligands for receptor protein-tyrosine kinases, including VEGF (Abedi and Zachary, 1997) . HUVEC were treated with VEGF (3 ng/ml), and anti-FAK immunoprecipitates were prepared and blotted with an anti-Tyr(P) mAb. As shown in Figure 4 , VEGF markedly increases FAK phosphorylation, and pretreatment of the cells with ATL-1 (10-100 nM) prior to VEGF treatment substantially reduces FAK activation without affecting cellular FAK levels. Immunofluorescent staining for phosphorylated FAK shows that in unstimulated (control) cells (Figure 5a ) and also in cells treated with ATL alone (Figure 5b ), staining is diffuse and focal adhesions are sparse and poorly defined. VEGF causes a striking increase in focal adhesions, mainly in parallel alignment at the cell edges (white arrows) (Figure 5c ). When cells were pretreated with ATL-1 (100 nM) before treatment with VEGF, the distribution of focal adhesions appeared similar to that of control cells (Figure 5d) . were treated with vehicle (medium plus 0.05% ethanol) or were exposed for 15 min to ATL-1 (100 nM) or VEGF (3 ng/ml) or were pretreated for 30 min with ATL-1 before exposure to VEGF for 15 min. Triton-soluble and Triton-insoluble cytoskeleton fractions were obtained as described in Materials and methods. The content of globular actin and filamentous actin present in the soluble and insoluble fractions, respectively, were analysed by immunoblotting using antiactin antibody, quantified by densitometry, and the F-actin/G-actin ratio content was expressed in arbitrary units. VEGF-induced p38 phosphorylation is inhibited by ATL-1. HUVEC were pretreated for 30 min with vehicle (medium plus 0.05% ethanol) or with the indicated increasing concentrations of ATL-1 (nM) and thereafter were exposed for 15 min to VEGF (3 ng/ml). The content of phosphorylated p38 was determined by immunoprecipitation using an anti-p38 antibody and immunoblotted with an antiphosphotyrosine antibody. Blots were analysed by densitometry, and the phospho-p38/total p38 ratio content was expressed in arbitrary units. A representative Western blot is shown and the densitometry shows mean7s.e.m. from three independent experiments performed with similar results. *Po0.05 in comparison with vehicle. **Po0.05 in comparison with VEGF. ATL inhibit VEGF-induced endothelial cell migration PFT Cezar-de-Mello et al VEGF-induced FAK association with the actin cytoskeleton is inhibited by ATL-1 VEGF activation of FAK phosphorylation occurs concomitantly with the association of FAK with the actin cytoskeleton. We examined whether the treatment of EC with ATL-1 affected this event. Figure 6c illustrates the VEGF-mediated colocalization of actin and FAK occurring mainly at focal adhesions at the cell periphery (white arrows), which completely disappears after preincubation of the cells with ATL-1 (100 nM) (Figure 6d ).
ATL-1 inhibition of VEGF-induced FAK association with the actin cytoskeleton is ALXR-dependent
While the principal LX actions occur via specific receptors on leukocytes, other reports have demonstrated the presence of these receptors on a variety of cell types, including EC (Takano et al., 1997; Gronert et al., 2000; Maderna et al., 2000) . Using an immunoblotting assay, we evaluated the content of phosphorylated FAK associated with F-actin ( Figure 7 ). ATL-1 inhibition of VEGF-induced association of FAK with the actin cytoskeleton was reverted after pre-exposure of EC to the LX receptor antagonist Boc2 (10 mM) (Gavins et al., 2003) for 10 min (Figure 7a , lane 5). The antagonist alone had no effect on the FAK phosphorylation state (Figure 7a , lane 6). The analog ATL-1 is known to bind to both LX receptor and cysLT1R with high affinity (Gronert et al., 2000) . To evaluate the possibility that ATL-1 transmits signals to the VEGF pathway through cysLT1R, EC were pretreated with the well-defined and reported selective cysLT1 antagonist montelukast (MLTK) (Singulair, Merck Sharp & Dohme) (Lynch et al., 1999) , which did not inhibit ATL-1 effects on VEGF-induced FAK association with the actin cytoskeleton ( Figure 7b , lane 5).
ATL-1 inhibits VEGF-induced actin cytoskeleton reorganization via ALXR
To confirm that ATL-1 was acting via its own receptor, the cells were treated with pertussis toxin (PTX), a specific inhibitor of G i -protein-linked receptors. Pretreatment of the cells with PTX (1 mg/ml) for 10 min blocked ATL-1 effect on actin reorganization (Figure 8d ), indicating that this effect does occur via ALXR. Moreover, in addition to PTX, Boc2 (10 mM) (Figure 8e ), but not MTLK (1 mM) (Figure 8f ), reverted ATL-1 inhibitory effect on VEGF-induced actin mobilization (Table 2) .
Discussion
Certain eicosanoids have potent biologic actions on vascular EC. Nie et al. (2000) have reported that endothelial 12-lipoxygenase (LO) activity and one of its products, 12(S)-HETE, are required for angiogenic responses. Along these lines, recent data show that ATL inhibit VEGF-induced endothelial cell migration PFT Cezar-de-Mello et al PGE 2 stimulates VEGF expression in EC (Pai et al., 2001) . Studies using molecular and pharmacological approaches have found that COX-2 and 12-LO, when overexpressed in carcinoma cells, enhance their angiogenic potential and stimulate tumor growth (Nie and Honn, 2004) . In the present study, we showed that ATL-1, a stable analog of ASA-triggered LX, was a potent inhibitor of VEGF-stimulated FAK activation and stress fiber formation in EC. During angiogenesis, migration of EC is essential for the organized formation of the vessel sprout (Arenberg and Strieter, 1999) . VEGF-induced EC migration requires the concerted activation of two complementary pathways leading to stress fiber formation: one involves a SAPK2/p38 MAP kinase-mediated actin polymerization, and the other involves the activation of FAK and the proper assembly of focal adhesions (Rousseau et al., 2000) . Previous studies have demonstrated that activation of VEGFR-2 by VEGF leads to the activation of SAPK2/p38 and actin cytoskeleton mobilization in EC; therefore, this pathway could be an important component of the signaling network that transduces VEGFgenerated migratory signals (Rousseau et al., 1997 (Rousseau et al., , 2000 Kanno et al., 2000) . The molecular mechanisms that couple VEGFR-2 to SAPK2/p38 may involve the small GTPase Cdc42, Src, and focal adhesion tyrosine kinase/proline-rich tyrosine kinase 2 (RAFTK/Pyk2) (Lamalice et al., 2004; McMullen et al., 2004) . Our results show that VEGF-induced p38 phosphorylation in HUVEC is significantly reduced by concomitant incubation with ATL-1, in concentrations similar to those that inhibit HUVEC migration (Fierro et al., 2002) . This is in good agreement with a recent work reporting that ATL block phosphorylation/activation of components of the p38 MAPK cascade in chemoattractant-stimulated human neutrophils (Ohira et al., 2004) . Whether the effects of ATL-1 on the p38 MAPK pathway are due to a direct interaction between the analog and components of this pathway is currently under investigation.
In EC exposed to VEGF, increased actin polymerization contributes to the reorganization of actin filaments into stress fibers. The findings presented here show that ATL-1 reduced VEGF-induced stress fibers formation in a dose-dependent manner. Thus, by causing the disassembly of actin stress fibers, the analog may disrupt the protrusion and contractile forces required for cell migration (Mitchison and Cramer, 1996) . The increase in F-actin generated through p38 activation likely results from phosphorylation of the F-actin polymerizing factor HSP27 downstream of the p38 pathway, which could be a possible target for ATL-1 action (Piotrowicz et al., 1998; Rousseau et al., 2000) .
Specific inhibition of p38 activity blocks actin polymerization and reorganization into stress fibers and inhibits cell migration, without affecting cell adhesion or cell proliferation (Rousseau et al., 1997) . Along these lines, the cotreatment of EC with ATL and SB 203580, a well-known p38 inhibitor, inhibits VEGFinduced actin reorganization in a synergic manner (data not shown).
Formation of stress fibers requires their anchorage to focal adhesions, which are complexes comprised of scaffolding and signaling proteins. Phosphorylation of FAK, by favoring the assembly/disassembly of focal adhesions, is a key event in regulating this anchoring process. Activation of FAK is followed by phosphorylation and recruitment of structural and membrane actin-anchoring proteins to focal adhesion plaques (Abedi and Zachary, 1997) . Le Boeuf et al. (2004) have recently demonstrated that the phosphorylation of FAK by VEGF involves two pathways. The first pathway requires the association of HSP90 with VEGFR2 and the activation of RhoA and ROCK, triggering the recruitment of paxillin and vinculin to FAK. The other pathway requires Src activation and subsequent recruitment of vinculin. We report that treatment of EC with ATL-1 results in a substantial reduction of VEGFinduced FAK phosphorylation. Whether the recruitment of focal adhesion proteins to phosphorylated FAK is also inhibited by the lipid analog is an important question for future investigation. Of interest, Figure 8 VEGF-induced actin cytoskeleton reorganization is inhibited by ATL-1 via ALXR. HUVEC plated on gelatin-coated coverslips were treated with vehicle (medium plus 0.05% ethanol) (a) or were exposed for 15 min to 3 ng/ml VEGF (b) or were pretreated for 10 min with vehicle (c), pertussis toxin (d), Boc2 (e) or montelukast (f) and for 30 min with ATL-1 before exposure to VEGF for 15 min. Cells were fixed and permeabilized, and F-actin content was detected using rhodamin-conjugated phalloidin. Coverslips were mounted onto microscope slides and analysed under an epifluorescence microscope (Olympus BX40). The results shown are representative of at least 15 different fields observed in each experiment and of three similar independent experiments. [
0 -heptenoic acid (IBOP), a mimetic of TXA 2 , another arachidonic acid metabolite, also decreased recruitment of FAK and vinculin to the a v b 3 integrin and reduced FAK and Src activation in response to VEGF (Ashton and Ware, 2004) .
Focal adhesion assembly and actin polymerization serve in concert to allow the actin reorganization required for cell migration. Our data show that VEGF-induced activation of FAK was accompanied by an increase in the association of the kinase with the actin cytoskeleton, an event abrogated by ATL-1, indicating that the analog effects are not only due to an inhibition of actin cytoskeleton reorganization but also to a misassembly of stress fibers resulting from a defect in the proper formation of focal contacts.
LX and ATL exert their actions via their own specific G-protein-coupled receptor, denoted ALXR. In addition to acting at its own receptor in EC, ATL-1 also competes at cysLT1-R, a receptor subtype that recognizes and responds to the peptidoleukotriene LTD 4 (Gronert et al., 2000) . The inhibitory effect of the ALXR antagonist Boc2, but not of the cysLT1R antagonist montelukast, on the actions of ATL-1 on VEGF-induced focal adhesion assembly and actin polymerization indicates that the inhibition is mediated by this particular receptor. Confirming that ATL-1 does not transmit signals to the VEGF pathway through the cysLT1 receptor, PTX but not montelukast blocked ATL-1 inhibitory effect on VEGF-induced actin mobilization. The receptor's intracellular downregulatory signals are currently under investigation and may involve tyrosine phosphatase activation analogous to the inhibitory effects of somatostatin on insulin-induced mitogenesis mediated via the SST-2 GPCR subtype (Buscail et al., 1995) or the transinactivation of the epidermal growth factor receptor mediated by bradykinin (Graness et al., 2000) . A recent report showed that, in human renal mesangial cells, LXA 4 inhibited plateletderived growth factor receptor activation (McMahon et al., 2002) , suggesting that modulation of receptor protein tyrosine kinase activation might be a target for these lipids.
Overall, our results indicate that an ASA-triggeredlipoxin, ATL-1, inhibits VEGF-induced EC migration, a fundamental step in the angiogenic process, via the concerted inhibition of actin polymerization and of the proper assembly of focal adhesions, an effect involving the ALXR. These data have important potential implications in the complex angiogenic environments, such as diabetic retinopathy or tumor, where EC are exposed to several mediators. A recent paper (Chiang et al., 2004) has documented ATL generation in a randomized human trial, pointing to the importance of a local 15-epi-lipoxin A 4 biosynthetic circuit within the vasculature. Hence, modulation of VEGF signaling could be a therapeutic target for lipoxin stable analogs, providing further benefits in a variety of diseases associated with angiogenesis.
Materials and methods
Materials
Fetal bovine serum (FBS) was purchased from Cultilab (Campinas, SP, Brasil). Trypsin was obtained from Amersham Biosciences (Buckinghamshire, UK). Boc2 peptide (Boc-PheLeu-Phe-Leu-Phe) was from Phoenix Pharmaceuticals Inc. (Belmont, CA, USA). Antibodies and protein A/G agarose were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA), and streptavidin from Caltag Laboratories (Burlingame, CA, USA). All other reagents and chemicals were from Sigma Chemical Co. (St Louis, MO, USA). 15-epi-16-(para-fluoro)-phenoxy-lipoxin A 4 (ATL-1), the stable 15-epi-Lipoxin A4 analog, was a generous gift from Brigham and Women's Hospital (Harvard Medical School, Boston, MA, USA).
Cell culture
Human umbilical vein endothelial cells (HUVEC) were isolated by collagenase digestion and propagated on gelatincoated (0.1%) tissue culture plates in medium 199 supplemented with 20% heat-inactivated FBS, 8 U/ml heparin, 50 U/ml penicillin and 15 mg/ml streptomycin. Only passages 2 and 3 were used in all experiments. Before each experiment, the cells were serum-starved for 12 h.
Immunocytochemistry and cytochemistry assays
For immunofluorescence microscopy, HUVEC (5 Â 10 4 ) were cultured on gelatin-coated glass coverslips. Following treatments, cells were washed with ice-cold PBS and fixed in 4% paraformaldehyde/4% sucrose for 20 min at room temperature. EC were then permeabilized with 0.2% Triton X-100 in PBS for 5 min. For double staining of FAK and phosphotyrosine, permeabilized cells were incubated with anti-FAK antibody (1:50) overnight at 41C and then sequentially incubated with anti-goat IgG Ab biotin-conjugated for 1 h, followed by streptavidin-conjugated CY3 (1:50) incubation. Cells were finally incubated with biotin-conjugated antiphosphotyrosine antibody (1:50) overnight at 41C followed by incubation with streptavidin-conjugated FITC (1:50) for 1 h at room temperature. Filamentous actin was stained with rhodamin-conjugated phalloidin (1:1000) for 2 h at room temperature. Coverslips were mounted onto microscope slides using a solution of 20 mM N-propylgalate and 80% glycerol in PBS. Microscopic analyses of double-stained and phalloidinstained cells were carried out using an epifluorescence microscope (Olympus BX40, Tokyo, Japan), and the images were acquired with a cooled-charged-coupled device camera (Photometrics, Tucson, AR, USA). The number of stress fibers per cell was quantified using the Saisam Software, 5.1.3 version (Microvision Instruments, France), and expressed as number of fibers/mm 2 .
Preparation of cell extracts HUVEC were detached by brief treatment with 0.05% Trypsin in PBS, collected by centrifugation and gently resuspended in serum-free medium. To obtain the whole-cell extracts, 10 6 cells were suspended in lysis buffer (50 mM HEPES, pH 6.4, 1 mM MgCl 2 , 10mM EDTA, 1% Triton X-100) containing the following protease inhibitors: 1 mM phenylmethylsulfonyl fluoride (PMSF), 1 mM benzamidine, 1 mM aprotinin, 1 mM leupeptin and 1 mM soybean trypsin inhibitor. Triton-soluble and Triton-insoluble cytoskeleton fractions were obtained by centrifuging cell lysates at 12 000 g for 10 min at 251C, recovering the supernatants (Triton-soluble fraction, containing G-actin), and suspending the pellets (Triton-insoluble fraction, containing F-actin) in the same lysis buffer under vigorous agitation.
Immunoprecipitation To obtain the cell extracts, 10 6 cells were suspended in lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1.5 mM MgCl 2 , 1.5 mM EDTA, 1% Triton X-100, 10% glycerol and 1 mg/ml DNAse) containing the following protease inhibitors: 1 mM phenylmethylsulfonyl fluoride (PMSF), 1 mM pepstatin, 1 mM aprotinin, and 1 mM leupeptin. After incubation with the primary antibody (overnight, 41C), protein A/G agarose (20 ml/mg protein) was added and samples were incubated at 41C under rotation for 2 h. The content of total and phosphorylated protein was analysed by immunoblotting.
Immunoblotting analysis
The total protein content in the cell extracts was determined by the Bradford method (Bradford, 1976) . Cell lysates were denatured in sample buffer (50 mM Tris-HCl, pH 6.8, 1% SDS, 5% 2-mercaptoethanol, 10% glycerol, 0.001% bromophenol blue) and heated in a boiling water bath for 3 min. Samples (30 mg total protein) were submitted to SDS-PAGE and transferred onto a polyvinylidene difluoride (PVDF) membrane. Rainbowt colored protein molecular weight markers (Amersham Pharmacia Biotech) were run in parallel to estimate molecular weights. Membranes were blocked with Tween-PBS (0.05% Tween-20) containing 2% bovine serum albumin. Primary antibodies used in Western analysis were anti-actin (1:500), anti-FAK (1:500), and anti-phosphotyrosine (1:200). The PVDF membranes were next washed three times with Tween-PBS, followed by 1 h incubation with appropriate secondary antibody conjugated to biotin. Then, the membranes were incubated with streptavidin-conjugated horseradish peroxidase (1:1000). Immunoreactive proteins were visualized by 3,3 0 -diaminobenzidine staining. The bands were quantified by densitometry, using Scion Image Software (Scion Co., Frederick, Maryland, MD, USA).
Statistical analysis
Statistical significance was assessed by ANOVA followed by Bonferroni's t-test, and Po0.05 was taken as statistically significant.
